Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Breeding for disease resilience is more cost-effective, study suggests
The study highlights the cost benefits of breeding animals to be resilient against disease.
Scientists develop mathematical models to estimate the economic value of disease resilience.

Breeding animals to be resilient against disease would be more cost-effective than breeding based on production traits, new research suggests.

Findings published in Genetics Selection Evolution show that breeding for optimum disease resilience could be three times more profitable than that of breeding based on production traits in disease-free conditions. 

Professor Andrea Doeschl-Wilson from the University of Edinburgh's Roslin Institute, which led the study, said: “Managing infectious disease continues to place a heavy toll on livestock producers and the animals they raise. By applying new statistical methods to big data from genomic and automated recording technologies, we can breed livestock that are more resilient to infection.”

In the study, researchers used data from a previous study of piglets with Porcine Respiratory and Reproductive Syndrome (PRRS) to develop mathematical models to estimate the economic value of disease resilience. 

According to their calculations, the value of selective breeding based on resistance and tolerance during infectious conditions was more than three times that of breeding based on production traits in disease-free conditions, demonstrating the high economic value of disease resilience. 

The team found that data or technologies that determine an animal’s response to infection based on its genes could be used to mitigate trade-offs between traits that contribute to resilience. 

They suggest that monitoring the level of infection in an animal over time, as well as tracking production traits, could be used to estimate the influence of resistance and tolerance on its response to infection.

 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.